112 related articles for article (PubMed ID: 2433427)
1. Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.
Rao KS; Aracava Y; Rickett DL; Albuquerque EX
J Pharmacol Exp Ther; 1987 Jan; 240(1):337-44. PubMed ID: 2433427
[TBL] [Abstract][Full Text] [Related]
2. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex.
Fiekers JF
J Pharmacol Exp Ther; 1985 Sep; 234(3):539-49. PubMed ID: 2411911
[TBL] [Abstract][Full Text] [Related]
3. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX
Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099
[TBL] [Abstract][Full Text] [Related]
4. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
[TBL] [Abstract][Full Text] [Related]
5. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning.
Albuquerque EX; Deshpande SS; Kawabuchi M; Aracava Y; Idriss M; Rickett DL; Boyne AF
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S182-203. PubMed ID: 2868960
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
[TBL] [Abstract][Full Text] [Related]
8. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.
Souccar C; Varanda WA; Daly JW; Albuquerque EX
Mol Pharmacol; 1984 May; 25(3):384-94. PubMed ID: 6328264
[TBL] [Abstract][Full Text] [Related]
9. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
Maleque MA; Souccar C; Cohen JB; Albuquerque EX
Mol Pharmacol; 1982 Nov; 22(3):636-47. PubMed ID: 6296656
[TBL] [Abstract][Full Text] [Related]
10. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX
Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955
[TBL] [Abstract][Full Text] [Related]
11. Development of desensitization during repetitive end-plate activity and single end-plate currents in frog muscle.
Giniatullin RA; Khamitov G; Khazipov R; Magazanik LG; Nikolsky EE; Snetkov VA; Vyskocil F
J Physiol; 1989 May; 412():113-22. PubMed ID: 2600828
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for antagonism of paraoxon by hemicholinium-3 analogues.
Bhattacharyya B; Sokoll MD; Flynn JR; Nyanda AM; Lee T; Cannon JG; Long JP
Arch Int Pharmacodyn Ther; 1990; 308():149-67. PubMed ID: 1965941
[TBL] [Abstract][Full Text] [Related]
13. The time course of miniature endplate currents and its modification by receptor blockade and ethanol.
Linder TM; Pennefather P; Quastel DM
J Gen Physiol; 1984 Mar; 83(3):435-68. PubMed ID: 6325590
[TBL] [Abstract][Full Text] [Related]
14. Synaptic depression in frog neuromuscular junction.
Glavinović MI
J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
[TBL] [Abstract][Full Text] [Related]
15. Interaction of analogs of histrionicotoxin with the acetylcholine receptor ionic channel complex and membrane excitability.
Maleque MA; Brossi A; Witkop B; Godleski SA; Albuquerque EX
J Pharmacol Exp Ther; 1984 Apr; 229(1):72-9. PubMed ID: 6323691
[TBL] [Abstract][Full Text] [Related]
16. A study of the novel synthetic analog (+/-)-depentylperhydrohistrionicotoxin on the nicotinic receptor-ion channel complex.
Maleque MA; Takahashi K; Witkop B; Brossi A; Albuquerque EX
J Pharmacol Exp Ther; 1984 Sep; 230(3):619-26. PubMed ID: 6088758
[TBL] [Abstract][Full Text] [Related]
17. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex.
Albuquerque EX; Akaike A; Shaw KP; Rickett DL
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S27-33. PubMed ID: 6327444
[TBL] [Abstract][Full Text] [Related]
18. End-plate currents evoked by paired stimuli in frog muscle fibres.
Magazanik LG; Nikolsky EE; Giniatullin RA
Pflugers Arch; 1984 Jun; 401(2):185-92. PubMed ID: 6332305
[TBL] [Abstract][Full Text] [Related]
19. The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.
Alkondon M; Albuquerque EX
J Pharmacol Exp Ther; 1989 Sep; 250(3):842-52. PubMed ID: 2476549
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the quantal composition, membrane potential and cholinoreceptor density on the temporal flow of the end plate current in the rat under conditions of acetylcholinesterase inhibition].
Giniatullin RA; Shvetsov AB
Neirofiziologiia; 1992; 24(3):269-79. PubMed ID: 1513401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
